The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
Open accessAbstract
Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high mTORC1 signaling may be an effective therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTORC1, which is well known for its function at the center of cancer metabolic reprogramming, promotes mitochondrial glutaminolysis via the migration of SIRT4-mediated inhibition of GLUD1189.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [189]
In the citing paper
“SIRT4 likewise appears to control tumorigenesis ((Jeong et al. 2013), (Csibi et al. 2013)) by inhibiting the high rate of glutamine metabolism associated with cancer growth;”
From The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications (2018) · cites this paper as Csibi et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 587
Dey, S., Murmu, N., Mondal, T., Saha, I., Chatterjee, S., Manna, R., Haldar, S., Dash, S. K., Sarkar, T. R., & Giri, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113801 · Cited by 58
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
der Vreken, A. V., Vanderkerken, K., Bruyne, E. D., Veirman, K. D., Breckpot, K., & Menu, E. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00535-1 · Cited by 61
Huang, G., Cui, F., Yu, F., Lu, H., Zhang, M., Tang, H., & Peng, Z. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.04.013 · Cited by 57
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 56
Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
Howie, D., Waldmann, H., & Cobbold, S. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00409 · Cited by 62
Proximity Labeling of Interacting Proteins: Application of BioID as a Discovery Tool
Li, P., Li, J., Wang, L., & Di, L. (2017) · PROTEOMICS · doi:10.1002/pmic.201700002 · Cited by 54
Li, J., Csibi, A., Yang, S., Hoffman, G. R., Li, C., Zhang, E. Y., Yu, J. J., & Blenis, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417015112 · Cited by 55
Self-citationRetractedMetabolic circuits in neural stem cells
Kim, D., Rhee, I., & Paik, J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1686-0 · Cited by 59
13C Isotope-Assisted Methods for Quantifying Glutamine Metabolism in Cancer Cells
Zhang, J., Ahn, W. S., Gameiro, P. A., Keibler, M. A., Zhang, Z., & Stephanopoulos, G. N. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00019-4 · Cited by 55
Self-citationHigh-throughput screening of Sirtuin family of genes in breast cancer
İğci, M., Kalender, M. E., Borazan, E., Bozgeyik, İ., Bayraktar, R., Bozgeyi̇k, E., Camcı, C., & Arslan, A. (2016) · Gene · doi:10.1016/j.gene.2016.04.023 · Cited by 57
Integration of superoxide formation and cristae morphology for mitochondrial redox signaling
Plecitá‐Hlavatá, L., & Ježek, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.010 · Cited by 57
mTOR signaling in immune cells and its implications for cancer immunotherapy
Zeng, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.038 · Cited by 54
Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
Chun, K., Kim, D., & Surh, Y. (2021) · Cells · doi:10.3390/cells10040758 · Cited by 56
Hwang, J. S., Kim, S. G., Shin, T. H., Jang, Y. E., Kwon, D. H., & Lee, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050997 · Cited by 54
Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
Kim, M., & Kim, H. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.3.221 · Cited by 54
PIK3CA mutant tumors depend on oxoglutarate dehydrogenase
Ilić, N., Birsoy, K., Aguirre, A. J., Kory, N., Pacold, M. E., Singh, S., Moody, S. E., DeAngelo, J. D., Spardy, N. A., Freinkman, E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617922114 · Cited by 55
Abdelmaksoud, N. M., Abulsoud, A. I., Abdelghany, T. M., Elshaer, S. S., Rizk, S. M., & Senousy, M. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154509 · Cited by 55
Chen, Z., Lin, J., Feng, S., Chen, X., Huang, H., Wang, C., Yu, Y., He, Y., Han, S., Zheng, L., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s189536 · Cited by 51
Liu, R., Chen, L., Wang, Y., Zhang, G., Cheng, Y., Feng, Z., Bai, X., & Liu, J. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108330 · Cited by 54
Regulation of mitochondrial plasticity by the i-AAA protease YME1L
Ohba, Y., MacVicar, T., & Langer, T. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0120 · Cited by 54
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
Shi, Q., Liu, T., Zhang, X., Geng, J., He, X., Nu, M., & Pang, D. (2016) · Oncology Letters · doi:10.3892/ol.2016.5021 · Cited by 52
Bunik, V. I., Artiukhov, A. V., Aleshin, V. A., & Mkrtchyan, G. V. (2016) · Biology · doi:10.3390/biology5040053 · Cited by 55
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Huang, G., & Zhu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157724 · Cited by 53
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56
Fu, R., Wang, X., Hu, Y., Du, H., Dong, B., Ao, S., Zhang, L., Sun, Z., Zhang, L., Lv, G., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4744 · Cited by 53
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768861 · Cited by 53
Villa-Cuesta, E., Holmbeck, M. A., & Rand, D. M. (2014) · Journal of Cell Science · doi:10.1242/jcs.142026 · Cited by 51
Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer
Huang, G., Cheng, J., Yu, F., Liu, X., Yuan, C., Liu, C., Chen, X.-L., & Peng, Z. (2016) · Oncology Reports · doi:10.3892/or.2016.4685 · Cited by 52
Sun, H., Huang, D., Liu, G., Jian, F., Zhu, J., & Zhang, L. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s156143 · Cited by 51
Maissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 52
Sirtuins and their influence on autophagy
Baeken, M. W. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30377 · Cited by 52
Targeting aberrant cancer metabolism – The role of sirtuins
Kleszcz, R., Paluszczak, J., & Baer‐Dubowska, W. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.021 · Cited by 51
Laxman, S., Sutter, B. M., Shi, L., & Tu, B. P. (2014) · Science Signaling · doi:10.1126/scisignal.2005948 · Cited by 55
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 50
You, L., Fan, Y., Liu, X., Shao, S., Guo, L., Noreldeen, H. A. A., Li, Z., Ouyang, Y., Li, E., Pan, X., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00285 · Cited by 49
Glutamine at focus: versatile roles in cancer
Vitto, H. D., Pérez-Valencia, J. A., & Radosevich, J. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4671-9 · Cited by 54
Cell energy metabolism and bone formation
Sautchuk, R., & Eliseev, R. A. (2022) · Bone Reports · doi:10.1016/j.bonr.2022.101594 · Cited by 51
The dual role of sirtuins in cancer: biological functions and implications
Yu, L., Li, Y., Song, S., Zhang, Y., Wang, Y., Wang, H., Yang, Z., & Wang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1384928 · Cited by 47
SIRT7‐mediated modulation of glutaminase 1 regulates TGF‐β‐induced pulmonary fibrosis
Choudhury, M., Yin, X., Schaefbauer, K. J., Kang, J. H., Roy, B., Kottom, T. J., LIMPER, A. H., & Leof, E. B. (2020) · The FASEB Journal · doi:10.1096/fj.202000564r · Cited by 47
Liu, R., Chen, L., Wang, Z., Zheng, X., Hou, Z., Zhao, D., Long, J., & Liu, J. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108503 · Cited by 47
Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4
Castex, J., Willmann, D., Kanouni, T., Arrigoni, L., Li, Y., Friedrich, M. E., Schleicher, M., Wöhrle, S., Pearson, M. A., Kraut, N., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.48 · Cited by 46
Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells
Du, L., Liu, X., Ren, Y., Li, J., Li, P., Jiao, Q., Meng, P., Wang, F., Wang, Y., Wang, Y., et al. (2020) · Theranostics · doi:10.7150/thno.44688 · Cited by 46
Glutamine metabolism: from proliferating cells to cardiomyocytes
Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 44
Kasinskas, R. W., Venkatasubramanian, R., & Forbes, N. S. (2014) · Integrative Biology · doi:10.1039/c4ib00001c · Cited by 44
Regulatory Effects of NAD + Metabolic Pathways on Sirtuin Activity
Zhang, N., & Sauve, A. A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.012 · Cited by 46
The Many Faces of Sirtuins: Sirtuins and the Warburg effect
Guarente, L. (2014) · Nature Medicine · doi:10.1038/nm.3438 · Cited by 43
Shaw, E., Talwadekar, M., Rashida, Z., Mohan, N., Acharya, A., Khatri, S., Laxman, S., & Kolthur‐Seetharam, U. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00212-19 · Cited by 42
Feng, W. W., & Kurokawa, M. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.100 · Cited by 44
The crisscross between p53 and metabolism in cancer
Mao, Y., & Jiang, P. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023109 · Cited by 45
Guo, L., Zhou, B. O., Liu, Z., Xu, Y., Lü, H., Xia, M., Guo, E., Shan, W., Chen, G., & Wang, C. (2016) · Tumor Biology · doi:10.1007/s13277-016-4984-3 · Cited by 42
The role of metabolic states in development and disease
Sieber, M., & Spradling, A. C. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.002 · Cited by 40
Zeng, G., Liu, H., & Wang, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.113 · Cited by 42
Metabolomic Profiles Reveal Potential Factors that Correlate with Lactation Performance in Sow Milk
Tan, C., Zhai, Z., Ni, X., Wang, H., Ji, Y., Tang, T., Ren, W., Long, H., Deng, B., Deng, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28793-0 · Cited by 42
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Lu, M., Wu, Y., Xia, M., & Zhang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1454161 · Cited by 41
Chemical and Physiological Features of Mitochondrial Acylation
Ringel, A. E., Tucker, S. A., & Haigis, M. C. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.10.023 · Cited by 43
Self-citation[NMF and cosmetology of cutaneous hydration].
Marty, J.-P. (2002) · PubMed · Cited by 41
Endogenous glutamine decrease is associated with pancreatic cancer progression
Roux, C., Riganti, C., Borgogno, S. F., Curto, R., Curcio, C., Catanzaro, V., Digilio, G., Padovan, S., Puccinelli, M. P., Isabello, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20545 · Cited by 40
Nuclear Functions of TOR: Impact on Transcription and the Epigenome
Laribee, R. N., & Weisman, R. (2020) · Genes · doi:10.3390/genes11060641 · Cited by 43
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39
Wild Type Mesenchymal Cells Contribute to the Lung Pathology of Lymphangioleiomyomatosis
Clements, D., Dongre, A., Krymskaya, V. P., & Johnson, S. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126025 · Cited by 39
Nakahara, Y., Yamasaki, M., Sawada, G., Miyazaki, Y., Makino, T., Takahashi, T., Kurokawa, Y., Nakajima, K., Takiguchi, S., Mimori, K., et al. (2016) · Oncology · doi:10.1159/000445323 · Cited by 39
Herrera, K. N. G., Zaganjor, E., Ishikawa, Y., Spinelli, J. B., Yoon, H., Lin, J., Satterstrom, F. K., Ringel, A. E., Mulei, S., Souza, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.076 · Cited by 39
Self-citationEnzyme Complexes Important for the Glutamate–Glutamine Cycle
McKenna, M. C., & Ferreira, G. C. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_4 · Cited by 35
Integrating T cell metabolism in cancer immunotherapy
Dugnani, E., Pasquale, V., Bordignon, C., Canu, A., Piemonti, L., & Monti, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.039 · Cited by 38
Enzymes in Metabolic Anticancer Therapy
Maggi, M., & Scotti, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7709-9_9 · Cited by 40
Mahjabeen, I., & Kayani, M. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146948 · Cited by 38
Shen, H., Ma, W., Hu, Y., Liu, Y., Song, Y., Fu, L., & Qin, Z. (2024) · Theranostics · doi:10.7150/thno.97320 · Cited by 38
Shu, Y., Lu, Y. Z., Pang, X., Zheng, W., Huang, Y., Li, J., Ji, J., Zhang, C., & Shen, P. (2016) · Oncotarget · doi:10.18632/oncotarget.12764 · Cited by 37
Jiang, Z., Wang, M., Xu, J., & Ning, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.015 · Cited by 37
Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context
Bi, J., Wu, S., Zhang, W., & Mischel, P. S. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.002 · Cited by 37
Tong, Y., Kai, J., Wang, S., Yu, Y., Xie, S., Zheng, H., Wang, Y., Liu, Y., Zhu, K., Guan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03901-7 · Cited by 37
Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis
Li, C.-Y., Wang, Y.-J., Huang, S.-W., Cheng, C.-S., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146902 · Cited by 37
Self-citationLovy, A., Ahumada-Castro, U., Bustos, G., Farías, P., González-Billault, C. E., Molgó, J., & Cárdenas, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00378 · Cited by 37
Priolo, C., Ricoult, S. J. H., Khabibullin, D., Filippakis, H., Yu, J. J., Manning, B. D., Clish, C. B., & Henske, E. P. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0379rc · Cited by 33
Self-citationMetabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses
Li, X., Li, Y., Hao, Q., Jin, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448535 · Cited by 37
SIRT4 Is a Regulator of Insulin Secretion
Zaganjor, E., Vyas, S., & Haigis, M. C. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.06.002 · Cited by 35
Self-citationZhao, L., Su, H., Liu, X., Wang, H., Feng, Y., Wang, Y., Chen, H., Dai, L., Lai, S., Xu, S., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00919-y · Cited by 35
Self-citationAmino acids downregulate SIRT4 to detoxify ammonia through the urea cycle
Hu, S.-H., Feng, Y.-Y., Yang, Y.-X., Ma, H., Zhou, S.-X., Qiao, Y.-N., Zhang, K.-H., Zhang, L., Huang, L., Yuan, Y., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00784-0 · Cited by 40
Jiang, L., Yuan, F., Yin, X., & Dong, J. (2014) · Connective Tissue Research · doi:10.3109/03008207.2014.942419 · Cited by 33
Lin, W.-P., Chen, W., Liu, W.-F., Xu, Z., & Zhang, L.-Q. (2019) · Immunology · doi:10.1111/imm.13123 · Cited by 32
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer
Grkovski, M., Goel, R., Krebs, S. S., Staton, K. D., Harding, J. J., Mellinghoff, I. K., Humm, J. L., & Dunphy, M. P. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229740 · Cited by 34
Physiological Role of Glutamate Dehydrogenase in Cancer Cells
Moreno‐Sánchez, R., Marín‐Hernández, Á., Gallardo‐Pérez, J. C., Pacheco-Velázquez, S. C., Robledo‐Cadena, D. X., Padilla-Flores, J. A., Saavedra, E., & Rodríguez‐Enríquez, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00429 · Cited by 34
Jiang, W., Ouyang, X., Ji, Z., Shi, W., Wu, Y., Yao, Q., Wang, Y., Yang, W., Xiang, L., & Yang, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216064 · Cited by 34
Escott, G. M., da Rosa, L., & Loss, E. D. S. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150126155032 · Cited by 35
Mito-Nuclear Communication in Hepatocellular Carcinoma Metabolic Rewiring
Mello, T., Simeone, I., & Galli, A. (2019) · Cells · doi:10.3390/cells8050417 · Cited by 34
Role of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 33
Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest
Hu, Y., Lin, J., Lin, Y., Chen, X., Zhu, G., & Huang, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.9877 · Cited by 32
Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?
Salvia, A. L., Espinosa-Olarte, P., Martínez, M. C. R., Antón-Pascual, B., & García‐Carbonero, R. (2021) · Cancers · doi:10.3390/cancers13071701 · Cited by 34
Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade
Choudhury, M., Schaefbauer, K. J., Kottom, T. J., Yi, E. S., Tschumperlin, D. J., & LIMPER, A. H. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0339oc · Cited by 33
The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb
Feng, R., Liu, F., Li, R., Zhou, Z., Lin, Z., Song, L., Deng, S., Li, Y., Nong, B., Xia, Y., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00938-z · Cited by 34
Lo, Y.-C., Lee, C.-F., & Powell, J. D. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000098 · Cited by 33
Prostate Cancer Energetics and Biosynthesis
Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 33
The metabolic importance of the glutaminase II pathway in normal and cancerous cells
Dorai, T., Pinto, J. T., Denton, T. T., Krasnikov, B. F., & Cooper, A. J. L. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114083 · Cited by 35
Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders
Xu, C.-Q., Li, J., Liang, Z., Zhong, Y.-L., Zhang, Z., Hu, X., Cao, Y., & Chen, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128270 · Cited by 32
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
Bhaoighill, M. N., & Dunlop, E. A. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.87 · Cited by 30
Yoshida, G. J. (2021) · Metabolites · doi:10.3390/metabo11010027 · Cited by 32
Avilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 33
The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer
Onyiba, C. I., Scarlett, C. J., & Weidenhofer, J. (2022) · Cancers · doi:10.3390/cancers14205118 · Cited by 31
Metadata
- Authors
- Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., Henske, E. P., Haigis, M. C., Cantley, L. C., Stephanopoulos, G., Yu, J., & Blenis, J.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Blenis, John
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 153
- Issue
- 4
- Pages
- 840-854
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3684628
- OpenAlex
- W2033228549
- Cited by
- 586
- References
- 59
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 52 · 2023: 37 · 2022: 47 · 2021: 42 · 2020: 49 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 55 · 2015: 56 · 2014: 52 · 2013: 13
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2021-04-15)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Glenn Foundation for Medical Research
- Pfizer
- University of Pennsylvania
- Johns Hopkins University
- Life Sciences Research Foundation
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- Fondation pour la Recherche Médicale
- National Research Foundation of Korea
- National Institutes of Health
- National Institute on Aging (R01AG032375, AG032375)
- National Heart, Lung, and Blood Institute (R01HL098216, R01HL121266, HL098216)
- National Cancer Institute (R01CA160458)
- National Institute of General Medical Sciences (GM51405, R01GM051405)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- mTORC1, SIRT4, glutamine metabolism, glutamine anaplerosis, glutamate dehydrogenase, ATF4, proteasomal degradation, cell proliferation, cancer metabolism, nutrient metabolism, tumor suppression, TCA cycle
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Embryo, Mammalian, Energy Metabolism, Glutamate Dehydrogenase, Glutamine, Humans, Neoplasm Transplantation, Neoplasms, Transcription, Genetic, Transplantation, Heterologous, Mitochondrial Proteins, Tumor Suppressor Proteins, Sirtuins, Multiprotein Complexes, Cell Proliferation, Mice, Activating Transcription Factors, Ubiquitination, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review